Intellia Therapeutics Inc Stock
Heavy losses for Intellia Therapeutics Inc today as the stock fell by -€5.540 (-8.530%). Currently there is a rather positive sentiment for Intellia Therapeutics Inc with 4 Buy predictions and 1 Sell predictions. With a target price of €60.00 there is a slightly positive potential of 8.774% for Intellia Therapeutics Inc compared to the current price of €55.16. So far the community has only identified positive things for Intellia Therapeutics Inc stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of Intellia Therapeutics Inc in the next few years
Performance of Intellia Therapeutics Inc vs. its peers
|Intellia Therapeutics Inc||-8.530%||-16.500%||-17.696%||330.097%||22.551%||214.302%||-|
|Organovo Holdings Inc.||-5.810%||-17.735%||-27.871%||-32.520%||-44.679%||-69.698%||-86.987%|
|Matinas BioPharma Holdings Inc||-1.440%||-8.219%||-24.294%||-||-27.568%||-||-|